Korean J Pediatr Hematol Oncol.  2002 Oct;9(2):166-176.

Treatment of B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoma

Affiliations
  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. hsahn@snu.ac.kr

Abstract

PURPOSE: We report here the improved survival rate of B-cell acute lymphoblstic leukemia (B-ALL) and B-cell non-Hodgkin's lymphoma (B-NHL) treated with a short, intensive multiagent chemotherapy and the treatment related toxicities and complications.
METHODS
From Oct. 1997 to Apr. 2002, 10 patients were enrolled. Patients were classified into three groups (Group A, B, C) according to tumor burden and were treated with CCG 5961, UKCCSG 9600, and LMB96 protocol. Induction chemotherapy included cyclophsophamide, vincristine, prednisolone, doxorubicin and high dose (HD) methotrexate (COPADM). Consolidation chemotherapy included HD methotrexate, HD cytarabine and etoposide (CYM; group B, CYVE; group C). In one patient, HD chemotherapy with stem cell rescue was used because residual disease was detected after consolidation chemotheapy.
RESULTS
Four patients were B-ALL and six patients were B-NHL (A; 1, B; 2, C; 7). Regimen was changed in 1 patient because of residual disease (B--CONCLUSION
This study confirms the effectiveness of short, intensive multiagent chemotherapy and we suggest early detection and management of toxic complication is the cornerstone of successful therapy.

Keyword

B-cell acute lymphoblstic leukemia (B-ALL); B-cell non-Hodgkin's lymphoma; Chemotherapy; Toxic complication

MeSH Terms

B-Lymphocytes*
Bone Marrow
Consolidation Chemotherapy
Cytarabine
Doxorubicin
Drug Therapy
Etoposide
Fever
Follow-Up Studies
Humans
Induction Chemotherapy
Leukemia
Lymphoma, B-Cell*
Lymphoma, Non-Hodgkin
Methotrexate
Neutropenia
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Prednisolone
Recurrence
Renal Dialysis
Stem Cells
Stomatitis
Survival Rate
Tumor Burden
Tumor Lysis Syndrome
Vincristine
Cytarabine
Doxorubicin
Etoposide
Methotrexate
Prednisolone
Vincristine
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr